Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer

Li, Lihui, Wang, Mingsong, Yu, Guangyang, Chen, Ping, Li, Hui, Wei, Dongping, Zhu, Ji, Xie, Li, Jia, Huixun, Shi, Jieyi, Li, Chunjie, Yao, Wantong, Wang, Yanchun, Gao, Qiang, Jeong, Lak Shin, Lee, Hyuk Woo, Yu, Jinha, Hu, Fengqing, Mei, Ju, Wang, Ping, Chu, Yiwei, Qi, Hui, Yang, Meng, Dong, Ziming, Sun, Yi, Hoffman, Robert M., Jia, Lijun·2014·JNCI: Journal of the National Cancer Institute

Abstract

BACKGROUND: A number of oncoproteins and tumor suppressors are known to be neddylated, but whether the neddylation pathway is entirely activated in human cancer remains unexplored. METHODS: NEDD8-activating enzyme (NAE) (E1) and NEDD8-conjugating enzyme (E2) expression and global-protein neddylation were examined by immunohistochemistry, immunoblotting, and real-time polymerase chain reaction analysis. Cell proliferation, clonogenic survival, migration, and motility in vitro, as well as tumor formation and metastasis in vivo, were determined upon neddylation inhibition by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Survival was analyzed with Kaplan-Meier methods and compared by the log-rank test. All statistical tests were two-sided. RESULTS: The entire neddylation pathway, including NEDD8-activating enzyme E1, NEDD8-conjugating enzyme E2, and global-protein neddylation, is overactivated in both lung adenocarcinoma and squamous-cell carcinoma. Compared with lung adenocarcinoma patients with low expression, those with high expression had worse overall survival (NEDD8-activating enzyme E1 subunit 1 [NAE1]: hazard ratio [HR] = 2.07, 95% confidence interval [CI] = 0.95 to 4.52, P = .07; ubiquitin-conjugating enzyme E2M (UBC12): HR = 13.26, 95% CI = 1.77 to 99.35, P = .01; global protein neddylation: HR = 3.74, 95% CI = 1.65 to 8.47, P = .002). Moreover, inhibition of neddylation by the NAE inhibitor MLN4924 statistically significantly suppressed proliferation, survival, migration, and motility of lung cancer cells in vitro and tumor formation and metastasis in vivo. At the molecular level, MLN4924 inactivated Cullin-RING E3 ligases, led to accumulation of tumor-suppressive Cullin-RING E3 ligase substrates and induced phorbol-12-myristate-13-acetate-induced protein 1 (NOXA)-dependent apoptosis or cellular senescence. CONCLUSIONS: Our study highlights the overactivated neddylation pathway in lung cancer development and as a promising therapeutic target.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/dju083

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 188

Metadata

Authors
Li, L., Wang, M., Yu, G., Chen, P., Li, H., Wei, D., Zhu, J., Xie, L., Jia, H., Shi, J., Li, C., Yao, W., Wang, Y., Gao, Q., Jeong, L. S., Lee, H. W., Yu, J., Hu, F., Mei, J., Wang, P., Chu, Y., Qi, H., Yang, M., Dong, Z., Sun, Y., Hoffman, R. M., & Jia, L.
Venue
JNCI: Journal of the National Cancer Institute
Published
2014-05-22
Volume
106
Issue
6
Pages
dju083-dju083
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2122405410
Cited by
188
References
3
FWCI
6.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer. https://app.cochat.ai/papers/10.1093/jnci/dju083
The paper
Li, L., Wang, M., Yu, G., Chen, P., Li, H., Wei, D., Zhu, J., Xie, L., Jia, H., Shi, J., Li, C., Yao, W., Wang, Y., Gao, Q., Jeong, L. S., Lee, H. W., Yu, J., Hu, F., Mei, J., . . . Jia, L. (2014). Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/dju083

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.